ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2683

Contribution of Subjective Patient Reported Components of Disease Activity Scores Differs in Disease Activity Measures and Their Changes over Time Are Closely Associated with Objective Measures

Yong Gil Hwang1, Juan (June) Feng2, Heather Eng2, Jason Lyons2, Anthony Fabio3 and Larry W. Moreland4, 1Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 2Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 3Department Of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, 4Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Disease Activity, patient outcomes and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Patient
reported measures are influenced by many non-rheumatoid arthritis (RA) factors and
they are reflected variably among various composite disease activity scores
(DAS). We investigated relative contribution of patient reported measures and
changes over time in two most widely used DAS.

Methods: For RA subjects
enrolled in the University of Pittsburgh RA Comparative Effectiveness Research
(RACER), cross-sectional and longitudinal analyses were performed to compare
relative contribution of subjective patient reported components to DAS28-C-Reactive
Protein (CRP) and Clinical Disease Activity Index (CDAI). Relative of the
contribution of the patient reported measures (Tender Joint Count (TJC) and
Patient Global Assessment (PtGA) in DAS28-CRP (DAS-P) and CDAI (CDAI-P) were
calculated at baseline and follow-up visit within 3 months. DAS28-CRP changes was
categorized by European League Against Rheumatism (EULAR) response criteria and
CDAI changes were grouped into major (improvement ≥ 14), moderate (≥
6), mild (<6). Wilcoxon signed ranks tests were performed for comparison.  Univariate
and multivariate regression analyses were performed to investigate factors
associated with changes of subjective domains.  

Results:   For the 740 subjects analyzed, age
was 60.2 ±13.7 (Mean±SD) years with disease duration of 14.4 ±12.4 years. 312
subjects had follow up visit within 3 months (1.7 ± 2.2 month).  DAS-P was
increased linearly with higher disease activity score.  In contrast, CDAI-P
remains similar with wider variation in remission or low disease activity (CDAI
≤ 10) (Figure.1). Significant reduction in the DAS28-P score was observed
at follow up visit in all response groups, with greater reduction of DAS28-P in
good responders. However, CDAI-P did not differ between the index and follow up
visit (Figure.2). Multivariate analyses showed Swollen Joint Count (SJC) and Physician
Global Assessment (PhGA) at the index visit had significant association with
DAS-P changes at the follow up visit. CDAI-P changes were also significantly
associated with HAQ (Table.1).

Conclusion:   Contribution
of patient reported components and their changes over time are substantially
different between DAS28-CRP and CDAI.  Objective findings such as SJC and PhGA predict
changes of subjective patient reported measures at the follow up visit.

 

Table.1 Associations of subjective patient reported component changes with clinical variables at baseline by multiple linear regression analyses (β unstandardized coefficient, SE: Standard Error, DAS-P: Subjective components of DAS28 relative to the total DAS28, CDAI-P: Subjective components of CDAI relative to the total CDAI, SJC: Swollen Joint Count, PhGA: Physician Global Assessment, HAQ: Health Assessment Questionnaire)

 

DAS-P change

CDAI- P change

 

β

SE

P value

β

SE

P value

SJC

-.029

.008

.001

-.293

.065

.000

PhGA

-.069

.022

.002

-.502

.171

.004

HAQ

-.181

.096

.061

-2.070

.758

.007

 


Disclosure: Y. G. Hwang, None; J. Feng, None; H. Eng, None; J. Lyons, None; A. Fabio, None; L. W. Moreland, None.

To cite this abstract in AMA style:

Hwang YG, Feng J, Eng H, Lyons J, Fabio A, Moreland LW. Contribution of Subjective Patient Reported Components of Disease Activity Scores Differs in Disease Activity Measures and Their Changes over Time Are Closely Associated with Objective Measures [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/contribution-of-subjective-patient-reported-components-of-disease-activity-scores-differs-in-disease-activity-measures-and-their-changes-over-time-are-closely-associated-with-objective-measures/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contribution-of-subjective-patient-reported-components-of-disease-activity-scores-differs-in-disease-activity-measures-and-their-changes-over-time-are-closely-associated-with-objective-measures/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology